Are ADCs having a moment? Is CAR-T safe? And who’s to blame for failed trials? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss why AbbVie is spending $10 ...
“What is happening with chemistry in America?” queries Matthew D. Hall, a biology group leader at the US National Center for Advancing Translational Sciences (NCATS) in a Twitter post July 8. “We’re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results